PJP (PJP) Stock Price & Analysis
PJP (PJP) rose 0.14% to USD 120.37 as of July 25, 2026 at 13:07 UTC, according to Nexqual real-time market data.
PJP last closed at USD 120.2; the session ranged USD 120.18–121.14 on volume of 64,538 shares. Market capitalization is —, with a 52-week range of USD 80.63–122.69 (PCX). Source: Nexqual, July 25, 2026 at 13:07 UTC.
Key Statistics (as of July 25, 2026 at 13:07 UTC)
| Price | USD 120.37 |
|---|---|
| Change | ▲ 0.14% (up) |
| Previous Close | USD 120.2 |
| Open | USD 120.92 |
| Day Range | USD 120.18 – 121.14 |
| 52-Week Range | USD 80.63 – 122.69 |
| Volume | 64,538 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (PJP)
Nexqual's technical model rates PJP "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 13:07 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 60.08 (neutral) |
| vs SMA50 | Above (USD 113.8) |
| MACD | 1.59 (positive) |
Financial Health Score (PJP)
Nexqual rates PJP's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 13:07 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PBE | Invesco Biotechnology & Genome | USD 89.59 | ▲ 0.28% |
| IHE | iShares U.S. Pharmaceutical ETF | USD 102.38 | ▲ 1.73% |
| XPH | State Street SPDR S&P Pharmaceu | USD 67.95 | ▼ 0.15% |
| PBJ | Invesco Food & Beverage ETF | USD 47.93 | ▼ 1.9% |
| FBT | First Trust Amex Biotech Index | USD 247.39 | ▲ 0.9% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 13:07 UTC. This page is informational and not investment advice.